Shanghai Bio-heart Biological Technology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CNY 204.24 million compared to CNY 361.45 million a year ago. Basic loss per share from continuing operations was CNY 0.84 compared to CNY 1.64 a year ago.
Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 HKD | -2.73% | +3.88% | -37.43% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.43% | 66.66M | |
+10.39% | 126B | |
-6.86% | 10.96B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Shanghai Bio-heart Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022